Stockscreener 앱 받기
16.82
0.06%
0.01
전일 마감가:
$16.81
열려 있는:
$17
하루 거래량:
234.39K
Relative Volume:
0.48
시가총액:
$5.96B
수익:
$4.89B
순이익/손실:
$-263.00M
주가수익비율:
-21.75
EPS:
-0.7734
순현금흐름:
$-167.84M
1주 성능:
+3.89%
1개월 성능:
+6.93%
6개월 성능:
+44.88%
1년 성능:
-15.52%
1일 변동 폭
$16.81
$17.34
1주일 범위
$16.03
$17.70
52주 변동 폭
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
명칭
Bausch Lomb Corp
전화
908-541-5456
주소
520 APPLEWOOD CRESCENT, VAUGHAN
BLCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
16.82 | 5.95B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
575.34 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.96 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.73 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.55 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
280.23 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | 개시 | Goldman | Neutral |
| 2025-05-02 | 재확인 | H.C. Wainwright | Buy |
| 2025-03-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 개시 | Raymond James | Outperform |
| 2024-05-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 개시 | Stifel | Hold |
| 2023-10-03 | 재개 | Evercore ISI | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 개시 | Needham | Hold |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-09-12 | 개시 | H.C. Wainwright | Buy |
| 2022-07-26 | 개시 | RBC Capital Mkts | Outperform |
| 2022-06-24 | 개시 | Evercore ISI | Outperform |
| 2022-06-06 | 개시 | Citigroup | Buy |
| 2022-05-31 | 개시 | Deutsche Bank | Hold |
| 2022-05-31 | 개시 | Goldman | Neutral |
| 2022-05-31 | 개시 | Guggenheim | Buy |
| 2022-05-31 | 개시 | JP Morgan | Neutral |
| 2022-05-31 | 개시 | Jefferies | Buy |
| 2022-05-31 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 개시 | Wells Fargo | Overweight |
| 2022-05-11 | 개시 | Cowen | Outperform |
모두보기
Bausch Lomb Corp 주식(BLCO)의 최신 뉴스
(BLCO) Daily Stock Insights (BLCO:CA) - news.stocktradersdaily.com
Oaktree Capital Management LP Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Will Bausch + Lomb Corporation (S2L) stock see valuation expansionWeekly Stock Report & Risk Managed Investment Strategies - Newser
Is Bausch + Lomb Corporation (S2L) stock a defensive play amid uncertainty2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Is Bausch + Lomb Corporation (S2L) stock a fit for income portfoliosJuly 2025 Rallies & Low Drawdown Momentum Ideas - Newser
Wall Street Cautious on Bausch + Lomb Corporation (BLCO), Here's Why - Finviz
Wall Street Cautious on Bausch + Lomb Corporation (BLCO), Here’s Why - Insider Monkey
Will Bausch + Lomb Corporation stock gain from lower inflationJuly 2025 Summary & Stock Timing and Entry Methods - Newser
Needham Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating - 富途牛牛
Balanced Hold Rating on Bausch + Lomb Amid Strategic Updates and Long-term Uncertainties - TipRanks
Is Bausch + Lomb Corporation (S2L) stock suitable for passive index fundsPortfolio Performance Report & Accurate Buy Signal Alerts - Newser
Morgan Stanley Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - AOL.com
Bausch + Lomb (NYSE:BLCO) Shares Gap UpTime to Buy? - MarketBeat
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - The Motley Fool
River Road Asset Management LLC Lowers Stock Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants - Eyes On Eyecare
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
Morgan Stanley Upgrades Bausch + Lomb Corp.(BLCO.US) to Buy Rating, Raises Target Price to $21 - 富途牛牛
(BLCO) Strategic Equity Report (BLCO:CA) - news.stocktradersdaily.com
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade - marketscreener.com
Why Bausch + Lomb (BLCO) Stock Is Up Today - Finviz
Bausch + Lomb upgraded at Morgan Stanley on pipeline - Seeking Alpha
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equal Weight, Adjusts PT to CA$29.41 From CA$19.64 - marketscreener.com
What analyst consensus says on Bausch + Lomb Corporation stock2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Can Bausch + Lomb Corporation (S2L) stock double in coming yearsTrade Analysis Report & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-12-02 01:18:08 - Newser
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? - Yahoo Finance
Handelsbanken Fonder AB Takes Position in Bausch + Lomb Corporation $BLCO - MarketBeat
(BLCO) Equity Trading Insights (BLCO:CA) - news.stocktradersdaily.com
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Behavioral Patterns of BLCO and Institutional Flows - news.stocktradersdaily.com
(BLCO) Market Performance Analysis (BLCO:CA) - news.stocktradersdaily.com
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Bausch + Lomb Lifts Guidance After Beating Earnings Forecasts - Finimize
Long Term Trading Analysis for (BLCO) (BLCO:CA) - news.stocktradersdaily.com
Citigroup Downgrades Bausch + Lomb (BLCO) - MSN
How Bausch + Lomb Corporation (S2L) stock responds to bond market2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Is Bausch + Lomb Corporation stock a buy for dividend growthJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Bausch + Lomb Corporation (S2L) stock worth buying before Fed actionMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
How big funds are accumulating Bausch + Lomb Corporation (S2L) stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
Trading (BLCO) With Integrated Risk Controls (BLCO:CA) - news.stocktradersdaily.com
Will Bausch + Lomb Corporation stock benefit from commodity supercycleJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Bausch + Lomb Corporation stock announce special dividend2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Why global investors buy Bausch + Lomb Corporation stockEntry Point & Weekly Breakout Opportunity Watchlist - newser.com
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic valueWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Bausch + Lomb to Engage at Citi Global Healthcare Conference - The Globe and Mail
Real time breakdown of Bausch + Lomb Corporation stock performancePortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Bausch Lomb Corp (BLCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.32%
0.55%
자본화:
|
볼륨(24시간):